Table 3 The univariate and multivariate analyses of treatment response in the training set

Location

0.38

0.38–2.42

0.93

Tumor size (cm)

0.72

0.50–1.03

0.07

0.81

0.47–1.40

0.45

Nature

0.81

0.26–2.55

0.72

MPD dilation (> 4 mm)

1.59

0.59–4.24

0.36

Lobulated lesion shape

0.32

0.12–0.87

0.03

0.94

0.22–4.04

0.93

Celiac artery involvement

0.57

0.21–1.58

0.28

Taller-than-wide shape in the longitudinal plane

0.17

0.06–0.45

 < 0.001

0.20

0.05–0.72

0.01

Taller-than-wide shape in the cross plane

0.57

0.21–1.58

0.28

Blood flow in color doppler

0.96

0.36–2.57

0.94

Presence of necrosis

0.34

0.10–1.19

0.09

0.61

0.11–3.72

3.72

Arterial phase (Iso/hypo-enhancement)

1.36

0.55–3.38

0.50

Venous phase (Rapid/slow washout)

0.33

0.11–1.03

0.06

0.10

0.01–1.11

0.06

TTP (≤ 25 s/ > 25 s)

8.08

2.90–22.51

 < 0.001

3.64

1.00–13.41

0.05

Peak_tumor/Peak_normal

1.69

1.25–2.29

0.001

1.51

1.05–2.17

0.03

Treatment (AG/AS)

1.94

0.78–4.82

0.16